Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure

Pulmonary Pharmacology and Therapeutics

Volumn 28, Issue 2, 2014, Pages 109-113

  Rinaldi, B ^a   Capuano, A ^a   Gritti, G ^a   Donniacuo, M ^a   Scotto Di Vettimo, A ^a   Sodano, L ^a   Rafaniello, C ^a   Rossi, F ^a   Matera, M G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Airway relaxant responses; Heart failure; AR blockers

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; CARBACHOL; G PROTEIN COUPLED RECEPTOR KINASE 2; MESSENGER RNA; METOPROLOL; NORADRENALIN; SALBUTAMOL; ADRBK1 PROTEIN, RAT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADRENALIN BLOOD LEVEL; AIRWAY RESPONSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; DOWN REGULATION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUNG FUNCTION; LUNG HEMODYNAMICS; LUNG PARENCHYMA; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; RAT MODEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE RELAXATION; TRACHEA; ANIMAL; BLOOD; BRONCHIAL HYPERREACTIVITY; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GENETICS; MALE; METABOLISM; PATHOPHYSIOLOGY; WISTAR RAT;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; ANIMALS; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPINEPHRINE; G-PROTEIN-COUPLED RECEPTOR KINASE 2; HEART FAILURE; MALE; METOPROLOL; NOREPINEPHRINE; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84904091099     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2014.04.005     Document Type: Article

References (28)

1. Snashall P.D., Chung K.F. Airway obstruction and bronchial hyperresponsiveness in left ventricular failure and mitral stenosis. Am Rev Respir Dis 1991, 144:945-956.
2. Matera M.G., Martuscelli E., Cazzola M. Pharmacological modulation of β-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure. Pulm Pharmacol Ther 2010 Feb, 23(1):1-8.
3. 1-receptor down-regulation in heart failure. Circ Res 1986, 59:297-309.
4. Hochman J.S., Bulkley B.H. Expansion of acute myocardial infarction: an experimental study. Circulation 1982, 65(7):1446-1450.
5. Borst M.M., Beuthien W., Schwencke C., LaRosé P., Marquetant R., Haass M., et al. Desensitization of the pulmonary adenylyl cyclase system a cause of airway hyperresponsiveness in congestive heart failure?. JAm Coll Cardiol 1999, 34:848-856.
6. Cabanes L.R., Weber S.N., Matran R., et al. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. NEngl J Med 1989, 320:1317-1322.
7. Pison C., Malo J.L., Rouleau J.L., Chalaoui J., Ghezzo H., Malo J. Bronchial hyperresponsiveness to inhaled methacholine in subjects with chronic left heart failure at a time of exacerbation and after increasing diuretic therapy. Chest 1989, 96:230-235.
8. Nishikawa M., Mak J.C., Shirasaki H., Harding S.E., Barnes P.J. Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary beta-adrenergic receptors in guinea pigs. Am J Respir Cell Mol Biol 1994, 10:91-99.
9. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Eur Heart J 2008, 29:2388-2442.
10. Sabbah H.N. Biologic rationale for the use of beta-blockers in the treatment of heart failure. Heart Fail Rev 2004, 9:91-97.
11. van der Woude H.J., Zaagsma J., Postma D.S., Winter T.H., van Hulst M., Aalbers R. Detrimental effects of β-blockers in COPD: a concern for nonselective β-blockers. Chest 2005, 127:818-824.
12. Ruffin R.E., McIntyre E.L., Latimer K.M., Ward H.E., Crockett A.J., Alpers J.H. Assessment of β-adrenoceptor antagonists in asthmatic patients. Br J Clin Pharmacol 1982, 13(suppl):325S-335S.
13. Salpeter S., Ormiston T., Salpeter E. Cardioselective beta-blockers for reversible airway disease. Cochrane Database Syst Rev 2002, CD002992.
14. Salpeter S., Ormiston T., Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005, CD003566.
15. Kubota Y., Umegaki K., Kagota S., Tanaka N., Nakamura K., Kunitomo M., et al. Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats. Biol Pharm Bull 2006, 29:1756-1758.
16. Da Prada M., Zürcher G. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 1976, 19:1161-1174.
17. Rinaldi B., Donniacuo M., Sodano L., Gritti G., Signoriello S., Parretta E., et al. Effects of sildenafil on the gastrocnemius and cardiac muscles of rats in a model of prolonged moderate exercise training. PLoS One 2013, 8:e69954.
18. Clark R.B., Knoll B.J., Barber R. Partial agonists and G protein-coupled receptor desensitization. Trends Pharmacol Sci 1999, 20:279-286.
19. Clark R.B., Rich T.C. Probing the roles of protein kinases in G-protein coupled receptor desensitization. Mol Pharmacol 2003, 64:1-3.
20. Spina D., Rigby P.J., Paterson J.W., Goldie R.G. Autoradiographic localization of β-adrenoceptors in asthmatic human lung. Am Rev Respir Dis 1989, 140:1410-1415.
21. Bond R.A., Spina D., Parra S., Page C.P. Getting to the heart of asthma: can "β blockers" be useful to treat asthma?. Pharmacol Ther 2007, 115:360-374.
22. Cazzola M., Matera M.G. β-Blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution. Am J Respir Crit Care Med 2008, 178:661-662.
23. Dickey B.F., Walker J.K.L., Hanania N.A., Bond R.A. β-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol 2010, 10:254-259.
24. Matera M.G., Calzetta L., Cazzola M. β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives. Drugs 2013, 73:1653-1663.
25. van Gestel Y.R.B.M., Hoeks S.E., Sin D.D., Stam H., Mertens F.W., Bax J.J., et al. Impact of cardioselective β-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med 2008, 178:695-700.
26. Nguyen L.P., Omoluabi O., Parra S., Frieske J.M., Clement C., Ammar-Aouchiche Z., et al. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol 2008, 38:256-262.
27. Hanania N.A., Singh S., El-Wali R., Flashner M., Franklin A.E., Garner W.J., et al. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther 2008, 21:134-141.
28. Hanania N.A., Mannava B., Franklin A.E., Lipworth B.J., Williamson P.A., Garner W.J., et al. Response to salbutamol in patients with mild asthma treated with nadolol. Eur Respir J 2010, 36:963-965.